Design, Synthesis and Structure of Peptides and Proteins news

<p>The researcher Meritxell Teixidó has been interviewed on the TVE2’s documentary ¡Qué animal!</p>
15 Oct 2019

Meritxell Teixidó, a researcher at IRB Barcelona, has been interviewed on the TVE2’s documentary ¡Qué animal! about her work with peptides from scorpion and bee venom in search of drugs that can reach the brain. "These poisons are able to reach the brain, which explains their toxicity. It is precisely this capacity  that attracts us to examine their applications," explains Teixidó. 

 

Link to TVE

 

<p>”la Caixa” Fellowship award ceremony</p>
20 Sep 2019

On 16 September, the ”la Caixa” Foundation presented the 79 grants for national and international research and innovation projects of excellence—among these four projects from the Institute for Research in Biomedicine (IRB Barcelona).

Among the beneficiaries of funding from ”la Caixa”, IRB Barcelona researchers Eduard Batlle and Raúl Méndez obtained two grants from the call for research projects in biomedicine and health, Meritxel Teixidó received a grant from the CaixaImpulse Programme, and Enrique Marcos was awarded a postdoctoral fellowship.

Characterised by a central theme “Questions for the future”,...

22 May 2019

It is estimated that one in four people will require brain treatment at some point. While there are drug candidates for most diseases of the brain, the blood-brain barrier (BBB) poses an impassable obstacle for most of these compounds and a bottleneck for the delivery of drugs that could cure these patients.

In the Peptides and Proteins Lab at the Institute for Research in Biomedicine (IRB Barcelona), Dr. Meritxell Teixidó headsa line of research that, after 10 years, has led to the development of a technology called Gate2Brain. This patented technology consists of three...

<p>"Art Made of Science – Microspheres". Source: Quo Artis</p>
5 Feb 2019

From 12/02 to 12/03, the Artist in Residence, Ayse Güll Süter, will be exhibiting her work: “Art made of Science-Microspheres” at the Sant Pau Art Nouveau Site (Recinto Modernista de Sant Pau).

This project has been done in collaboration with the Fundación Quo Artis, the Sant Pau Art Nouveau Site, and IRB Barcelona.

<p>Biennal Ciutat i Ciència</p>
16 Jan 2019

From 7 to 11 February, the general public will have the opportunity to participate in activities related to ageing, nanoscience and climate change, among others.

IRB Barcelona will be taking part in the Biennal event through three initiatives that target the public.

<p>Biennal Ciutat i Ciència</p>
16 Jan 2019

From 7 to 11 February, the general public will have the opportunity to participate in activities related to ageing, nanoscience and climate change, among others.

IRB Barcelona will be taking part in the Biennal event through three initiatives that target the public.

<p>Giant Yellow Israeli scorpion. Image: Ester Inbar</p>
8 Jan 2019

RNE's "Inquietamente" programme has interviewed Meritxell Teixidó, IRB Barcelona research associate, about the study based on scorpion venom. "We saw that there was a peptide in the scorpion venom, chlorotoxin, which has the ability to reach the central nervous system and then act as toxin, "said Teixidó.

Link to RNE

 

<p>Teresa Tarragó. Image: El Periódico</p>
7 Dec 2018

Expansión, El Periódico de Catalunya and Diario de Córdoba, among other media, have published articles about the biotechnologist Iproteos, a company created in 2011 by the scientists Teresa Tarragó and Ernest Giralt and based on the transfer of a technology developed atIRB Barcelona and the University of Barcelona (UB). The company has launched a project to develop a therapeutic strategy, designed by IBEC, to treat solid tumours, which account for 90-95% of cancer cases.

Link to El Periódico de Catalunya...

<p>Source: IRB Barcelona</p>
15 Nov 2018

TV3, RAC1, ABC, World Pharma News, Neuro Science, among other national and international media, have published articles about the research from the Peptides and Proteins Lab at IRB Barcelona. The study in question is inspired on the scorpion venom to deliver medicines to brain. The scientists have modified a peptide from the venom and used it as a shuttle to transport drugs across the barrier that protects the brain.

Link to TV3

Link to...

<p>Giant Yellow Israeli scorpion. Image: Ester Inbar</p>
14 Nov 2018

Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain. 

The barrier, which protects the brain, prevents drugs used for the treatment of neurological diseases and brain tumours from entering the organ.